Advancing Oral RIPTACTM Therapeutics Towards the Clinic
Time: 11:30 am
day: Post-Conference Focus Day
Details:
- Novel heterobifunctional small molecule RIPTAC technology platform
- Leveraging protein-protein interactions and other mechanistic insights
- Halda’s Prostate Cancer RIPTAC Program
